Literature DB >> 22456327

Cathelicidin gene therapy: a new therapeutic option in ulcerative colitis and beyond?

A Ahluwalia, A S Tarnawski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22456327     DOI： 10.1038/gt.2012.23

Source DB:  PubMed          Journal:  Gene Ther        ISSN： 0969-7128            Impact factor:   5.250


× No keyword cloud information.
  4 in total

Review 1.  Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer.

Authors:  Jimmy Yip Chuen Chow; Zhi Jie Li; William Ka Kei Wu; Chi Hin Cho
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

2.  Cathelicidin suppresses colon cancer development by inhibition of cancer associated fibroblasts.

Authors:  Michelle Cheng; Samantha Ho; Jun Hwan Yoo; Deanna Hoang-Yen Tran; Kyriaki Bakirtzi; Bowei Su; Diana Hoang-Ngoc Tran; Yuzu Kubota; Ryan Ichikawa; Hon Wai Koon
Journal:  Clin Exp Gastroenterol       Date:  2014-12-17

3.  Cathelicidin - A Novel Potential Marker of Pediatric Inflammatory Bowel Disease.

Authors:  Paulina Krawiec; Elżbieta Pac-Kożuchowska
Journal:  J Inflamm Res       Date:  2021-01-22

4.  Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial Peptide.

Authors:  Christopher Patrick; Gen-Sheng Wang; David E Lefebvre; Jennifer A Crookshank; Brigitte Sonier; Chandra Eberhard; Majid Mojibian; Christopher R Kennedy; Stephen P J Brooks; Martin L Kalmokoff; Mariantonia Maglio; Riccardo Troncone; Philippe Poussier; Fraser W Scott
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.